Progestins and recurrence in breast cancer survivors.
Chlebowski
Rowan T
RT
Anderson
Garnet L
GL
D001943:Breast Neoplasms / Q000473:pathology*; D020847:Estrogen Receptor Modulators / Q000008:administration & dosage; D015914:Estrogen Replacement Therapy / Q000009:adverse effects* / Q000379:methods; D005060:Europe; D005260:Female; D019584:Hot Flashes / Q000188:drug therapy; D006801:Humans; D008593:Menopause; D009364:Neoplasm Recurrence, Local / Q000139:chemically induced*; D009652:Norpregnenes / Q000008:administration & dosage; D011372:Progestins / Q000008:administration & dosage* / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D017741:Survivors; D016896:Treatment Outcome
D020847:Estrogen Receptor Modulators; D009652:Norpregnenes; D011372:Progestins; C027385:tibolone